MarketWatch
US · 3 hrs ago
✦ 78◉ Centre
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
GSK announced a $10.6 billion acquisition of biotech company Nuvalent, its largest deal in eight years, to expand its cancer drug portfolio after previous reductions in that area.
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!